Neuropediatrics 2014; 45(01): 056-060
DOI: 10.1055/s-0033-1341601
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Mild Phenotype in a Male with Pyruvate Dehydrogenase Complex Deficiency Associated with Novel Hemizygous In-Frame Duplication of the E1α Subunit Gene (PDHA1)

J. Steller
1   Division of Genetics and Metabolism, Department of Pediatrics, University of California–Irvine, Orange, California, United States
2   Division of Clinical Genetics, Children's Hospital of Orange County, Orange, California, United States
,
J. J. Gargus
1   Division of Genetics and Metabolism, Department of Pediatrics, University of California–Irvine, Orange, California, United States
2   Division of Clinical Genetics, Children's Hospital of Orange County, Orange, California, United States
,
L. H. Gibbs
3   Department of Radiology, University of California–Irvine, Orange, California, United States
,
A. N. Hasso
3   Department of Radiology, University of California–Irvine, Orange, California, United States
,
V. E. Kimonis
1   Division of Genetics and Metabolism, Department of Pediatrics, University of California–Irvine, Orange, California, United States
2   Division of Clinical Genetics, Children's Hospital of Orange County, Orange, California, United States
› Author Affiliations
Further Information

Publication History

28 August 2012

16 February 2013

Publication Date:
09 April 2013 (online)

Preview

Abstract

Pyruvate dehydrogenase complex (PDHC) deficiency is an inborn error of metabolism that occurs most commonly due to mutations in the X-linked E1α subunit gene (PDHA1). We report a novel duplication of PDHA1 associated with a mild phenotype in a 15-year-old boy who was diagnosed with PDHC deficiency at 4 years of age following a history of seizures and lactic acidosis. The novel c.1087_1119 mutation in exon 11 resulted in an in-frame duplication of 11 amino acids. Measurements of PDHC activity in cultured skin fibroblasts were low, corresponding to 18.6 and 11.6% of the mean with respect to prior controls, whereas the E1 PDH component was absent. He has borderline intellectual functioning and maintains normal lactate levels on a ketogenic diet in between relapses due to illness. Review of the literature reveals wide variation of clinical phenotype in patients with mutations of the E1α subunit gene (PDHA1). There appears to be a higher incidence of normal or borderline intellectual ability in individuals who have insertions or deletions that are in-frame versus those that are out-of-frame. Furthermore, there is no correlation between mean residual PDH activity and phenotype in these patients.